Group 1: Phillips 66 - Phillips 66 announced a definitive agreement to acquire the remaining 50% ownership interest in WRB Refining LP from subsidiaries of Cenovus Energy [1] Group 2: Tandem Diabetes Care - Oppenheimer analyst maintained an Outperform rating for Tandem Diabetes Care but lowered the price target from $44 to $22 [2] - Tandem Diabetes Care shares fell 1.5% to settle at $12.37 [5] Group 3: Cintas - Cintas is recommended for purchase, with a suggestion to buy more if the upcoming quarter's results are disappointing [2] - Cintas shares fell 0.3% to close at $201.40 [5] Group 4: Intuitive Surgical - Intuitive Surgical reported second-quarter revenue of $2.44 billion, exceeding analyst estimates of $2.35 billion [3] - The company reported second-quarter adjusted earnings of $2.19 per share, beating analyst estimates of $1.93 per share [3] - Intuitive Surgical shares fell 3.8% to close at $449.98 [5]
Jim Cramer: This Is The Right Time To Buy This Energy Stock